Question · asked by 1 review
Tranexamic acid vs alternative haemostatic agents: Control of epistaxis: episodes of re‐bleeding over 10 days
- Population
- adults with nasal haemorrhage (epistaxis)
- Intervention
- Tranexamic acid
- Comparison
- alternative haemostatic agents
- Outcome
- Control of epistaxis: episodes of re‐bleeding over 10 days
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Tranexamic acid vs other haemostatic agent Control of epistaxis: episodes of re‐bleeding over 10 days · adults with nasal haemorrhage (epistaxis) Tranexamic acid for patients with nasal haemorrhage (epistaxis) (2018) · Cochrane Headline outcomes only | no estimate extracted | 10 participants | GRADE not reported |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Tranexamic acid for patients with nasal haemorrhage (epistaxis) 2018 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.